SE410734B - Forfarande for framstellning av 2-substituerade imidazoliner med hypoglykemisk aktivitet - Google Patents
Forfarande for framstellning av 2-substituerade imidazoliner med hypoglykemisk aktivitetInfo
- Publication number
- SE410734B SE410734B SE7607325A SE7607325A SE410734B SE 410734 B SE410734 B SE 410734B SE 7607325 A SE7607325 A SE 7607325A SE 7607325 A SE7607325 A SE 7607325A SE 410734 B SE410734 B SE 410734B
- Authority
- SE
- Sweden
- Prior art keywords
- hypoglykemic
- activity
- procedure
- preparation
- substituted imidazolines
- Prior art date
Links
- 150000002462 imidazolines Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7607325A SE410734B (sv) | 1976-06-24 | 1976-06-24 | Forfarande for framstellning av 2-substituerade imidazoliner med hypoglykemisk aktivitet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7607325A SE410734B (sv) | 1976-06-24 | 1976-06-24 | Forfarande for framstellning av 2-substituerade imidazoliner med hypoglykemisk aktivitet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7607325L SE7607325L (sv) | 1977-12-25 |
| SE410734B true SE410734B (sv) | 1979-10-29 |
Family
ID=20328313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7607325A SE410734B (sv) | 1976-06-24 | 1976-06-24 | Forfarande for framstellning av 2-substituerade imidazoliner med hypoglykemisk aktivitet |
Country Status (1)
| Country | Link |
|---|---|
| SE (1) | SE410734B (sv) |
-
1976
- 1976-06-24 SE SE7607325A patent/SE410734B/sv not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE7607325L (sv) | 1977-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE435059B (sv) | Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar | |
| SE441827B (sv) | Forfarande for framstellning av fenoxiaminopropanoler | |
| NO774404L (no) | Fremgangsmaate for fremstilling av dimetyleter | |
| SE7804839L (sv) | Forfarande for framstellning av urea | |
| SE423544B (sv) | Analogiforfarande for framstellning av imidazolderivat med antifungisk aktivitet | |
| SE441354B (sv) | Forfarande for framstellning av meta-fenoxibensaldehyd | |
| SE420314B (sv) | Analogiforfarande for framstellning av indolizinderivat | |
| SE435387B (sv) | Forfarande for framstellning av antracyklinglykosider | |
| NO143992C (no) | Fremgangsmaate for fremstilling av heksanitrostilben | |
| NO834236L (no) | Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater | |
| NO772089L (no) | Fremgangsm}te ved fremstilling av 2-deoksystreptaminderivater med antibakteriell aktivitet | |
| AR211570A1 (es) | Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo | |
| SE434263B (sv) | Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan | |
| NO774067L (no) | Fremgangsmaate for fremstilling av cellulosemasse | |
| SE7707471L (sv) | Forfarande for framstellning av 5-m-tolyloxiuracil | |
| SE7712218L (sv) | Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner | |
| SE7805676L (sv) | Nytt forfarande for framstellning av alkaloider av leurosintypen | |
| SE436744B (sv) | Forfarande for framstellning av prostacyklinderivat | |
| SE419083B (sv) | Analogiforfarande for framstellning av nikotinoylamino-triazinderivat | |
| SE7709402L (sv) | Forfarande for framstellning av tetrahydropyridinderivat | |
| SE7709142L (sv) | Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler | |
| SE7702071L (sv) | Forfarande for framstellning av sulfoacetaler | |
| SE436496B (sv) | Forfarande for framstellning av dibensotiofenderivat | |
| SE7700572L (sv) | Forfarande for framstellning av tienopyridinderivat | |
| SE7709636L (sv) | Forfarande for framstellning av 4-oxokapronitril |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7607325-3 Effective date: 19930109 Format of ref document f/p: F |